The emergence of glycopeptide resistance in enterococci results in a severe clinical problem. Efforts to limit the spread of glycopeptide-resistant enterococci are now considered essential. The many ways in which the resistant strains can disseminate, both in the community and in hospitals, are a source of difficulty in reaching that goal.